Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Timothy Reid

Family Medicine Janesville, WI Medical Doctor

NPI 1023160520 CMS profile 45871

1010 N Washington St, Janesville, WI 53548

Open in the dashboard

General payments

$70,860

149 records reported · program years 2019–2022

Research payments

$2,750

Paid to them · 5 records reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Timothy Reid of Janesville, WI is reported in the CMS Open Payments database as having received $70,860 across 149 general payments and $2,750 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2022 Research $1,250 1
2021 General $156 2
2021 Research $1,500 4
2020 General $14,513 21
2019 General $56,192 126

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Reid
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Timothy Reid were reported at $0. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Timothy Reid Family Medicine median Middle half National median
2019 $56,192 $150 $41–$543 $163
2020 $14,513 $120 $32–$415 $114
2021 $156 $137 $35–$551 $132
2022 $0 $137 $37–$512 $149
2023 $0 $149 $42–$545 $160
2024 $0 $156 $44–$560 $164
2025 $0 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Novo Nordisk Inc $47,946 70 payments
  2. Sanofi-Aventis U.S. LLC $20,319 36 payments
  3. Becton, Dickinson and Company $1,125 1 payment
  4. AstraZeneca Pharmaceuticals LP $740 5 payments
  5. Dexcom, Inc. $156 4 payments
  6. Merck Sharp & Dohme Corporation $120 10 payments
  7. Janssen Scientific Affairs, LLC $88 1 payment
  8. Genzyme Corporation $70 1 payment
  9. Janssen Pharmaceuticals, Inc $69 7 payments
  10. Amarin Pharma Inc. $63 3 payments
  11. Other $164 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33,611 25 payments
  2. Consulting Fee $27,940 8 payments
  3. Travel and Lodging $5,870 23 payments
  4. Food and Beverage $3,181 83 payments
  5. Education $258 10 payments
Products named General payments · program years 2019–2022
  1. Victoza $22,812 31 payments
  2. TOUJEO Diabetes $10,767 15 payments
  3. Ozempic $7,839 12 payments
  4. RYBELSUS $6,351 8 payments
  5. Tresiba $5,852 20 payments
  6. SOLIQUA 100/33 Diabetes $4,615 10 payments
  7. TOUJEO Endocrinology $2,862 3 payments
  8. Xultophy 100/3.6 $2,288 18 payments
  9. FARXIGA $620 4 payments
  10. SOLIQUA 100/33 Endocrinology $468 1 payment
  11. Other $1,116 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2022
  1. Sanofi-Aventis U.S. LLC $2,750 5 payments

Records

154 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record